Physician

Mario A Lammoglia, M.D.

According to 2025 Medicare claims, Mario Lammoglia, M.D. (NPI: 1174575104) practices internal medicine in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is MARIO A LAMMOGLIA MD PA (NPI: 1053598755; TIN: 742892527) and primary practice location at 77845-4082. Lammoglia is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542) and Main Street Rural Health Hickory ACO LLC (ACO ID: A5334), participating under the MSSP model.

Lammoglia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 657 traditional Medicare patients, billed 3,805 HCPCS/CPT codes, and received $478,273 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,475 prescription claims across 844 beneficiaries totaling $1,768,519 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 60 claims. Open Payments data shows 139 records totaling $2,883. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $554,453 to $1,768,519. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $27,575 and ending at $25,663.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,010	7,231	$709,964
2016	1,173	8,586	$733,643
2017	1,005	8,456	$700,369
2018	914	7,167	$634,300
2019	852	6,090	$590,319
2020	814	6,062	$541,027
2021	831	5,667	$495,335
2022	820	5,253	$539,330
2023	833	5,212	$572,318
2024	657	3,805	$478,273

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	558	7,646	$554,453
2016	578	7,233	$509,388
2017	593	7,169	$597,109
2018	597	6,731	$689,297
2019	707	8,001	$944,310
2020	735	8,285	$1,195,739
2021	764	8,726	$1,461,131
2022	804	9,044	$1,696,965
2023	830	9,152	$1,791,589
2024	844	9,475	$1,768,519

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	15	$27,575
2017	N/R	N/R	N/R
2018	N/R	20	$41,521
2019	N/R	14	$30,120
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	13	$31,577
2023	33	60	$60,299
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	216	227	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	483	545	$86
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	170	178	$56
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	418	491	$10
J2785	Injection, regadenoson, 0.1 mg	162	648	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,147	49,977	$936,915
Multaq	Dronedarone Hcl	255	10,084	$253,017
Repatha Sureclick	Evolocumab	208	6,844	$128,654
Xarelto	Rivaroxaban	139	6,210	$107,538
Praluent Pen	Alirocumab	70	2,634	$42,844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$2,883	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mario A. Lammoglia, M.D.?

Tedicare shows public-source Medicare data for Mario A. Lammoglia, M.D. (NPI 1174575104), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mario A. Lammoglia, M.D. have ACO affiliation data?

Mario A. Lammoglia, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542) and Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334).

What billing organization is linked to Mario A. Lammoglia, M.D.?

Mario A. Lammoglia, M.D. is linked to MARIO A LAMMOGLIA MD PA (billing NPI 1053598755) in the available physician profile data.

Does Mario A. Lammoglia, M.D. have Open Payments data?

Mario A. Lammoglia, M.D. has 139 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.